July 24, 2026

Sonida Senior Living, Inc. (SNDA) Stock Report: Navigating Growth in Senior Care with a 38.5% Revenue Surge

Sonida Senior Living, Inc. (SNDA) stands at the forefront of the senior housing industry in the United States, offering a comprehensive suite of services to aging..

Bicycle Therapeutics plc (BCYC) Stock Report: Exploring a 226% Potential Upside in the Biotechnology Sector

Bicycle Therapeutics plc (BCYC), a clinical-stage biopharmaceutical company, is garnering attention from investors for its innovative approach to tackling diseases that current therapeutics struggle to address...

Fortrea Holdings Inc. (FTRE) Stock Analysis: Biotech Play with Mixed Signals and Growth Potential

Fortrea Holdings Inc. (NASDAQ: FTRE) is navigating the intricate landscape of the biotechnology industry with a focus on providing comprehensive research solutions for biopharmaceutical and medical..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Navigating a 52.40% Potential Upside in the Biotech Sector

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, has captured investor attention with its promising therapeutic innovations in the healthcare..

Personalis, Inc. (PSNL) Investor Outlook: Analyzing Growth Potential Amidst a 13.54% Upside

Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector specializing in cancer genomics, is making waves in the diagnostics and research industry. As investors..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Assessing Growth Potential Amid a Challenging Market Landscape

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a medical technology firm focused on innovative solutions for bunion deformity correction. Despite its niche specialization in the healthcare..

AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a 58.61% Potential Upside

AnaptysBio, Inc. (ANAB), a clinical-stage biotechnology firm rooted in San Diego, is making waves in the healthcare sector with its promising pipeline of immunology therapeutics. As..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Understanding the Unchanged Landscape in Biotech

KalVista Pharmaceuticals, Inc. (KALV), a key player in the biotechnology sector, operates from its headquarters in Framingham, Massachusetts. As a company dedicated to developing groundbreaking oral..

InMode Ltd. (INMD): Investor Outlook Highlights Strong Global Presence and Growth Potential

InMode Ltd. (NASDAQ: INMD), an innovative player in the healthcare sector, continues to capture investor attention with its robust portfolio of minimally invasive aesthetic medical products...

Tectonic Therapeutic, Inc. (TECX): Analyst Ratings Signal a Potential 148% Upside for Innovative Biotech Player

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has emerged as a fascinating player in the biotechnology sector, capturing investor attention with its cutting-edge approach to drug discovery and..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a 7.19% Potential Upside in the Biotech Sector

Investors eyeing the biotechnology sector may find Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) an intriguing, albeit challenging, opportunity. With a market capitalization of $518.02 million, this..

COMPASS Pathways Plc (CMPS) Stock Analysis: A 109% Potential Upside in the Psychedelic Therapeutics Space

For investors exploring opportunities in the burgeoning field of mental health therapeutics, COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing proposition. Specializing in innovative psychedelic therapies,..

Arbutus Biopharma (ABUS): A Promising Biotech with Over 15% Potential Upside

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company headquartered in Warminster, Pennsylvania, has captured the attention of investors with its promising pipeline and significant potential..

Akso Health Group (AHG) Stock Analysis: Exploring Challenges and Opportunities in the Evolving Healthcare Market

Investors with a keen eye on the healthcare sector, particularly in the expansive Chinese market, might find Akso Health Group (NASDAQ: AHG) an intriguing, albeit complex,..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: A 40.40% Revenue Growth Story with Double-Digit Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector, is rapidly making its mark in the niche market of rare disease treatments. With..

Zenas BioPharma, Inc. (ZBIO): Investor Outlook with 35.93% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a prominent player in the biotechnology sector, offers an intriguing prospect for investors seeking exposure to the healthcare industry. With a..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 22.75% Potential Upside in the Healthcare Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the medical devices industry with its innovative approach to diabetes management. The company, headquartered in Irvine, California,..

Replimune Group, Inc. (REPL) Stock Analysis: Assessing the 1.98% Potential Upside in Biotech

Replimune Group, Inc. (NASDAQ: REPL), a burgeoning player in the biotechnology sector, offers investors a unique opportunity to explore innovative cancer therapies through its cutting-edge oncolytic..

Claritev Corporation (CTEV) Stock Analysis: Exceptional Growth Potential with a 61.87% Upside

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector, is making waves with its comprehensive data analytics and cost management solutions. With a market..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges in the Healthcare Staffing Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands at a critical juncture, as it navigates the complexities of the healthcare staffing industry. With a market capitalization of..

Search

Funds

July 24, 2026

Search

Funds

July 24, 2026

FTSE 100

Funds